Soleno Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
SLNO
CUSIP
834203309
Type
Equity
Class
COM
Num filings
23
Total reported value, excl. options
$20.8 M
Manager Report Date Value ($000) Shares Option Type